Related Experiment Video
Updated: Jul 5, 2026
07:35
A Non-invasive Way to Isolate and Phenotype Cells from the Conjunctiva
Published on: July 5, 2017
CTLA-4 polymorphisms are not associated with ocular inflammatory disease.
1Department of Ophthalmology, King's College London, London, UK.
Tissue Antigens
|May 24, 2008
Summary
Genetic variations in Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) were investigated for links to Behcet's disease and intermediate uveitis. No association was found between CTLA-4 single nucleotide polymorphisms and these autoimmune conditions.
Area of Science:
- Immunogenetics
- Autoimmune Diseases
- Ophthalmology
Background:
- Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) is a key regulator of immune responses.
- Single nucleotide polymorphisms (SNPs) in genes like CTLA-4 are implicated as genetic factors in autoimmunity.
- Behcet's disease (BD) and intermediate uveitis are autoimmune conditions with known genetic associations, including HLA.
Purpose of the Study:
- To investigate the association of specific CTLA-4 gene polymorphisms (-318C/T and 49A/G) with Behcet's disease (BD) and idiopathic intermediate uveitis.
- To determine if these CTLA-4 SNPs correlate with disease manifestations in BD or outcomes in intermediate uveitis.
Main Methods:
- Genotyping of CTLA-4 SNPs -318C/T and 49A/G using polymerase chain reaction-sequence specific primers (PCR-SSP) assay.
- Analysis of DNA samples from 236 patients with BD (UK and Middle East) and 143 patients with intermediate uveitis, alongside healthy controls from corresponding geographical regions.
Main Results:
- No significant association was found between the studied CTLA-4 polymorphisms and the presence of Behcet's disease in either UK or Middle Eastern cohorts.
- Similarly, no association was observed between these CTLA-4 SNPs and idiopathic intermediate uveitis.
- The study found no correlation between CTLA-4 polymorphisms and disease manifestations in BD or the clinical outcome in intermediate uveitis patients.
Conclusions:
- The investigated CTLA-4 polymorphisms (-318C/T and 49A/G) do not appear to be genetic risk factors for Behcet's disease or intermediate uveitis.
- Despite known HLA associations for both conditions, CTLA-4 polymorphisms, unlike those in other autoimmune diseases, show no link.
- Further research is needed to elucidate the underlying genetic and molecular mechanisms contributing to the pathogenesis of BD and intermediate uveitis.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...